1. Int J Mol Sci. 2019 Jan 18;20(2):403. doi: 10.3390/ijms20020403.

Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT 
Disease.

González-Sánchez P(1)(2)(3), Satrústegui J(4)(5)(6), Palau F(7)(8)(9), Del Arco 
A(10)(11)(12).

Author information:
(1)Departamento de Biología Molecular, Centro de Biología Molecular Severo 
Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de 
Madrid (CSIC-UAM), 28049 Madrid, Spain. pgsanchez@cbm.csic.es.
(2)Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 
28029 Madrid, Spain. pgsanchez@cbm.csic.es.
(3)Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), 28006 
Madrid, Spain. pgsanchez@cbm.csic.es.
(4)Departamento de Biología Molecular, Centro de Biología Molecular Severo 
Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de 
Madrid (CSIC-UAM), 28049 Madrid, Spain. jsatrustegui@cbm.csic.es.
(5)Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 
28029 Madrid, Spain. jsatrustegui@cbm.csic.es.
(6)Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), 28006 
Madrid, Spain. jsatrustegui@cbm.csic.es.
(7)Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 
28029 Madrid, Spain. fpalau@sjdhospitalbarcelona.org.
(8)Instituto de Recerca Sant Joan de Déu and Hospital Sant Joan de Déu, 08950 
Barcelona, Spain. fpalau@sjdhospitalbarcelona.org.
(9)Division of Pediatrics, University of Barcelona School of Medicine, 08036 
Barcelona, Spain. fpalau@sjdhospitalbarcelona.org.
(10)Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 
28029 Madrid, Spain. araceli.arco@uclm.es.
(11)Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), 28006 
Madrid, Spain. araceli.arco@uclm.es.
(12)Facultad de Ciencias Ambientales y Bioquímica, Centro Regional de 
Investigaciones Biomédicas, Universidad de Castilla la Mancha, 45600 Toledo, 
Spain. araceli.arco@uclm.es.

The pathology of Charcot-Marie-Tooth (CMT), a disease arising from mutations in 
different genes, has been associated with an impairment of mitochondrial 
dynamics and axonal biology of mitochondria. Mutations in ganglioside-induced 
differentiation-associated protein 1 (GDAP1) cause several forms of CMT 
neuropathy, but the pathogenic mechanisms involved remain unclear. GDAP1 is an 
outer mitochondrial membrane protein highly expressed in neurons. It has been 
proposed to play a role in different aspects of mitochondrial physiology, 
including mitochondrial dynamics, oxidative stress processes, and mitochondrial 
transport along the axons. Disruption of the mitochondrial network in a 
neuroblastoma model of GDAP1-related CMT has been shown to decrease Ca2+ entry 
through the store-operated calcium entry (SOCE), which caused a failure in 
stimulation of mitochondrial respiration. In this review, we summarize the 
different functions proposed for GDAP1 and focus on the consequences for Ca2+ 
homeostasis and mitochondrial energy production linked to CMT disease caused by 
different GDAP1 mutations.

DOI: 10.3390/ijms20020403
PMCID: PMC6359725
PMID: 30669311 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.